| Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion RM Bell, MM Mocanu, DM Yellon Journal of molecular and cellular cardiology 50 (6), 940-950, 2011 | 654 | 2011 |
| Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathway RM Bell, DM Yellon Journal of the American College of Cardiology 41 (3), 508-515, 2003 | 393 | 2003 |
| Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations DJ Hausenloy, G Baxter, R Bell, HE Bøtker, SM Davidson, J Downey, ... Basic research in cardiology 105, 677-686, 2010 | 285 | 2010 |
| Contrast-induced nephropathy following angiography and cardiac interventions R Rear, RM Bell, DJ Hausenloy Heart 102 (8), 638-648, 2016 | 267 | 2016 |
| Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS RM Bell, DM Yellon Journal of molecular and cellular cardiology 35 (2), 185-193, 2003 | 235 | 2003 |
| PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning MM Mocanu, RM Bell, DM Yellon Journal of molecular and cellular cardiology 34 (6), 661-668, 2002 | 228 | 2002 |
| SGLT2 inhibitor, canagliflozin, attenuates myocardial infarction in the diabetic and nondiabetic heart VG Lim, RM Bell, S Arjun, M Kolatsi-Joannou, DA Long, DM Yellon JACC: Basic to Translational Science 4 (1), 15-26, 2019 | 155 | 2019 |
| Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy V Sharma, RM Bell, DM Yellon Expert opinion on pharmacotherapy 13 (8), 1153-1175, 2012 | 120 | 2012 |
| Pivotal role of NOX‐2‐containing NADPH oxidase in early ischemic preconditioning RM Bell, AC Cave, S Johar, DJ Hearse, AM Shah, MJ Shattock The FASEB journal 19 (14), 2037-2039, 2005 | 117 | 2005 |
| The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice RM Bell, DM Yellon Cardiovascular research 52 (2), 274-280, 2001 | 108 | 2001 |
| Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling HJ Whittington, I Harding, CIM Stephenson, R Bell, DJ Hausenloy, ... Cardiovascular research 99 (4), 694-704, 2013 | 103 | 2013 |
| 9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection RM Bell, HE Bøtker, RD Carr, SM Davidson, JM Downey, DP Dutka, ... Basic research in cardiology 111, 1-13, 2016 | 100 | 2016 |
| The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart RM Bell, HL Maddock, DM Yellon Cardiovascular research 57 (2), 405-415, 2003 | 97 | 2003 |
| Nitric oxide as a mediator of delayed pharmacological (A1 receptor triggered) preconditioning; is eNOS masquerading as iNOS? RM Bell, CCT Smith, DM Yellon Cardiovascular research 53 (2), 405-413, 2002 | 85 | 2002 |
| Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals M Heightman, J Prashar, TE Hillman, M Marks, R Livingston, HA Ridsdale, ... BMJ open respiratory research 8 (1), e001041, 2021 | 80 | 2021 |
| Effect of hyperglycaemia and diabetes on acute myocardial ischaemia–reperfusion injury and cardioprotection by ischaemic conditioning protocols C Penna, I Andreadou, M Aragno, C Beauloye, L Bertrand, A Lazou, ... British journal of pharmacology 177 (23), 5312-5335, 2020 | 78 | 2020 |
| The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio … SM Davidson, S Arjun, MV Basalay, RM Bell, DI Bromage, HE Bøtker, ... Basic Research in Cardiology 113, 1-11, 2018 | 76 | 2018 |
| SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models I Andreadou, RM Bell, HE Bøtker, CJ Zuurbier Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (7), 165770, 2020 | 72 | 2020 |
| Characterization of the Langendorff perfused isolated mouse heart model of global ischemia–reperfusion injury: impact of ischemia and reperfusion length on infarct size and LDH … X Rossello, AR Hall, RM Bell, DM Yellon Journal of cardiovascular pharmacology and therapeutics 21 (3), 286-295, 2016 | 72 | 2016 |
| The C‐terminal activation domain of the STAT‐1 transcription enhances ischemia/reperfusion‐induced apoptosis in cardiac myocytes A Stephanou, TM Scarabelli, PA Townsend, R Bell, D Yellon, RA Knight, ... The FASEB Journal 16 (13), 1-17, 2002 | 72 | 2002 |
